COVID-19The Acute Respiratory Clinic (ARC) at National Jewish Health in Denver, CO, is an outpatient clinic for adults with suspected COVID-19 or other acute respiratory illnesses with exacerbations. Health care providers working in the ARC have received special training with personal protective equipment (PPE) and caring for people who are suspected of having COVID-19. Our goal is to quickly identify if a patient has COVID-19 or another respiratory illness and to start the appropriate course of treatment.

The highest level of precautions are taken in the ARC to ensure the safety of the patients, their visitors and the health care providers. At this time, patients are seen by appointment only. Visitors are discouraged, but for those who require help, one visitor is permitted.


Acute Respiratory Clinic Highlights

  • Separate entrance to protect patients
  • COVID-19 testing
  • Regular virus testing
  • Negative Pressure Rooms to prevent escape of germs
  • Specially trained health care providers


Symptoms Evaluated at ARC

  • COVID-19 symptoms, including fever, cough, breathlessness and diarrhea
  • Lung disease with worsening symptoms potentially related to COVID-19


Related Conditions


Related Programs


Clinical Trials

Response to COVID-19 Vaccines in People with Chronic Conditions

National Jewish Health researchers are studying the antibody response to COVID-19 vaccines in people with chronic conditions.

Learn More

Reasons to Choose National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked #1 or #2 in Pulmonology by U.S. News & World Report for 25 consecutive years
  • Ranked in the top 5 percent of hospitals in the nation by HCAHPS
  • Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 5 percent of organizations funded for research by the NIH, providing patients access to hundreds of active clinical trials
  • 122-history of focus on care, research and education serving patients from around the world with lung, heart, immune and related disorders